All three microRNAs were upregulated and repressed NEDD4L [21], EP300 [58], and SMAD7 [59] in breast cancer, influencing epithelial–mesenchymal transition, tumoral transformation, and therapy response. This evidence concerns the gene SMAD7 and breast cancer.